GlassScriptPhysician profile
Mark I Anderson
NPI 1215900303
$1,890.33
in general payments reported to CMS, 2019-2025
18 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3.82 · 2023: $945 · 2024: $101 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662 · Travel and Lodging: $211 · Education: $13.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.76 |
| Travel and Lodging | $210.89 |
| Education | $13.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $398.61 | 2023-2025 | Aquabeam Robotic System |
| Coloplast Corp | $336.09 | 2023-2025 | Torosa, Titan |
| Progenics Pharmaceuticals, INC. | $213.69 | 2023-2025 | Pylarify |
| Edap Technomed INC | $201.20 | 2023 | |
| Valencia Technologies Corporation | $166.90 | 2025 | Ecoin Device Kit |
| Sumitomo Pharma America, INC. | $100.22 | 2024-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $81.80 | 2023 | Prolaris |
| Boston Scientific Corporation | $81.31 | 2025 | Lithovue |
| Intuitive Surgical, INC. | $73.50 | 2025 | |
| Accord Healthcare, INC. | $61.58 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $46.16 | 2023 | Bard Urinary Drainage Bag |
| Telix Pharmaceuticals | $35.64 | 2025 | Illuccix |
| Endo USA, INC. | $24.39 | 2025 | Xiaflex |
| Abc Home Medical Supply, INC. | $19.24 | 2024 | |
| Antares Pharma, INC. | $17.91 | 2025 | Xyosted |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.41 | 2023 | Myrbetriq |
| Pfizer INC. | $13.86 | 2023 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.